Higher BMI = Less Neutropenia With CDK4/6 Inhibitor for Early Breast Cancer

(MedPage Today) -- A higher body mass index (BMI) translated into less neutropenia and fewer discontinuations among women with early hormone receptor (HR)-positive breast cancer treated with a CDK4/6 inhibitor, a secondary analysis of the randomized...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news